Health ❯ Healthcare

Chronic Conditions

Diabetes Obesity Hypertension Heart Disease Type 2 Diabetes Diabetes Management Cardiovascular Health Asthma Cardiovascular Disease Obesity Management

34 ARTICLES

4d ago

GLP‑1 Use Reaches 11% of U.S. Adults as New Evidence Spurs Policy and Safety Scrutiny

Large comparative studies report limited quality‑of‑life gains despite big weight losses, prompting pilot coverage programs and warnings about online and compounded access risks.

5 ARTICLES

last wk.

Secret‑Shopper Study Finds Online GLP‑1 Sellers Quickly Approve Prescriptions With Little Clinician Oversight

23 ARTICLES

last wk.

Medicare Launches GLP‑1 Bridge to Offer Select Weight‑Loss Drugs for $50 a Month

8 ARTICLES

last wk.

Melatonin Lowers Chronic Musculoskeletal Pain, University of Sydney Analysis Finds

3 ARTICLES

last wk.

Study Finds GLP‑1 Diabetes Drugs Linked to Fewer Deaths and Limb Procedures in People With PAD

8 ARTICLES

last wk.

FDA Scientists Say Evidence Lacks for Allowing Seven Popular Peptides in Compounding

4 ARTICLES

2w ago

Updated COVID Vaccine Linked to Lower Risk of Major Heart Events in Large VA Study

3 ARTICLES

3w ago

Severe GLP‑1 Overdoses Rise as Online Access and Compounded Vials Expand

5 ARTICLES

4w ago

Meta-Analysis Finds Tirzepatide Produces Largest Average Weight Loss Among FDA‑Approved GLP‑1s

3 ARTICLES

4w ago

FDA Clears Dexcom Stelo as First OTC CGM for Children

16 ARTICLES

4w ago

Wearable Data Show People Move Less After Starting GLP‑1 Weight‑Loss Drugs

4 ARTICLES

4w ago

Study Finds Large Gaps in Guideline-Based Testosterone Prescribing at Michigan Medicine

4 ARTICLES

4w ago

FDA Grants Accelerated Approval to Sanofi’s Tzield for Children With Stage 3 Type 1 Diabetes

3 ARTICLES

4w ago

Nearly Half of Working-Age Americans Say They Can’t Afford Health Care

3 ARTICLES

last mo.

GLP‑1 Agonists Linked to Lower Clot Risk and Mortality in People With Obesity and Autoimmune Disease

Chronic Conditions

GLP‑1 Use Reaches 11% of U.S. Adults as New Evidence Spurs Policy and Safety Scrutiny

Secret‑Shopper Study Finds Online GLP‑1 Sellers Quickly Approve Prescriptions With Little Clinician Oversight

Medicare Launches GLP‑1 Bridge to Offer Select Weight‑Loss Drugs for $50 a Month

Melatonin Lowers Chronic Musculoskeletal Pain, University of Sydney Analysis Finds

Study Finds GLP‑1 Diabetes Drugs Linked to Fewer Deaths and Limb Procedures in People With PAD

FDA Scientists Say Evidence Lacks for Allowing Seven Popular Peptides in Compounding

Oxford Tool Predicts Individual Risk of Serious Statin-Related Muscle Disorders

Study Finds Common GLP‑1 Use and Misuse Among People With Eating Disorders

Nationwide Recall of 25 mg Chlorthalidone Covers 11,460 Bottles

FDA Approves First Generic Single‑Dose Flu Drug

Never miss stories about

Chronic Conditions

FDA Expands Capvaxive Use to At‑Risk Children and Teens

Updated COVID Vaccine Linked to Lower Risk of Major Heart Events in Large VA Study

Severe GLP‑1 Overdoses Rise as Online Access and Compounded Vials Expand

Meta-Analysis Finds Tirzepatide Produces Largest Average Weight Loss Among FDA‑Approved GLP‑1s

FDA Clears Dexcom Stelo as First OTC CGM for Children

Wearable Data Show People Move Less After Starting GLP‑1 Weight‑Loss Drugs

Study Finds Large Gaps in Guideline-Based Testosterone Prescribing at Michigan Medicine

FDA Grants Accelerated Approval to Sanofi’s Tzield for Children With Stage 3 Type 1 Diabetes

Nearly Half of Working-Age Americans Say They Can’t Afford Health Care

GLP‑1 Agonists Linked to Lower Clot Risk and Mortality in People With Obesity and Autoimmune Disease

Never miss stories about

Chronic Conditions